Physician profile
Mohammad Qureshi
NPI 1588002505
$7,020.08
in general payments reported to CMS, 2019-2025
44 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $595 · 2021: $1,412 · 2022: $1,129 · 2023: $1,447 · 2024: $1,144 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,396 · Education: $80.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,395.92 |
| Education | $80.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,342.25 | 2019-2025 | Wavewriter Alpha Prime 16, Rezum Generator, Ams 700 |
| Abbvie INC. | $1,192.45 | 2021-2025 | |
| Medtronic, INC. | $654.61 | 2022-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Amgen INC. | $535.12 | 2019-2025 | Uplizna, Aimovig |
| Curonix LLC | $481.68 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $307.00 | 2023-2025 | |
| Lilly USA, LLC | $218.48 | 2022-2024 | Amyvid, Emgality |
| Teva Pharmaceuticals USA, INC. | $179.87 | 2020-2025 | Austedo Xr, Austedo Xr |
| Scilex Pharmaceuticals INC. | $153.31 | 2021-2024 | Ztlido |
| Eisai INC. | $141.72 | 2022-2025 | |
| Averitas Pharma INC. | $131.15 | 2023-2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $111.48 | 2019-2020 | |
| Biogen, INC. | $110.22 | 2021-2022 | |
| Axsome Therapeutics, INC. | $103.09 | 2025 | Symbravo |
| Biohaven Pharmaceutical Holding Company LTD. | $102.80 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.